Nano pharmaceuticals are revolutionizing medical science by leveraging nano medicine to render effective healthcare, especially in developing countries. The technology is yet in evolution stages and promises to bring advancement not only in therapeutics but also in detecting diseases and targets. Also, one factor that is making it popular is its cost-effectiveness. the global nano pharmaceutical drugs market is anticipated to grow over $79.29 billion by 2028, growing at a CAGR of 9.12%, during the forecast period from 2018 to 2028.

Top Driver: Increasing in the incidence of chronic diseases such as infectious diseases, cancer, and cardiovascular diseases will drive the market growth

Rise in the incidence of chronic diseases such as infectious diseases, cancer, and cardiovascular diseases, is paving way for expansion of nano-pharmaceuticals market. Nano pharmaceuticals are also referred to as nanotechnology-based pharmaceuticals. The advancement is becoming an integral part of medical science and has potential to treat diseases at cellular level. Primarily, nano pharmaceuticals are particles in the size range 10 to 1,000 nanometers of specific matter used to manufacture drugs. As a result of composition and shape, the medicines have several benefits to offer over the normal medicines Increase in the incidence of chronic diseases such as cancer, infectious diseases, and cardiovascular diseases, is one of the main factors fuelling nano-pharmaceuticals market. Prominent players in the nano-pharmaceuticals market are investing on large scale in order to introduce improved medicines in the market. The advancements in the nano pharmaceuticals are likely to address therapeutics for critical diseases, which are yet to be explored. This can be explained by an example of Jazz Pharmaceuticals, a key player of nano-pharmaceuticals market. In August 2017, the company received FDA approval for Vyxeos. Vyxeos is basically used for the treatment of acute myeloid leukemia.

Liposomes segment to Make Crucial Contribution for Growth of Global Nano pharmaceuticals Market

The pace of research and developments underway for nano pharmaceuticals, global nano-pharmaceuticals market is projected to grow at a significant pace in the course of the forecast period. On the other side, factors such as less solubility of nano-pharmaceuticals, toxicity issues, and its functioning need to be addressed on a wider scale. If not, these factors may hinder the growth of the nano pharmaceutical market in the tenure of forecast period. Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure surrounding an aqueous core domain, and their size can vary from 50 nm to several micrometers. Liposomes have attractive biological properties, including general biocompatibility, biodegradability, isolation of drugs from the surrounding environment and the ability to entrap both hydrophilic and hydrophobic drugs. Through the addition of agents to the lipid membrane, or the alteration of the surface chemistry, liposome properties, such as size, surface charge and functionality, can be easily tuned.

North America dominated to witness fastest growth in Global Nano pharmaceuticals Market

Nano pharmaceuticals Market substantial advancement in the research and development activities in North America, the region is expected to dominate in the global nano-pharmaceuticals market. Besides, the region is witnessing rapid adoption rate of nano-pharmaceuticals for advanced therapeutics. Also, presence of prominent players is another main factor which is fuelling the expansion of nano-pharmaceutical market.

The growth of the North America nano pharmaceutical drugs market. However, the market of Europe and Asia-Pacific are expected to grow at an impressive CAGR in terms of revenue during the forecast period.

Players to Focus on Nano pharmaceuticals Market

Nano-pharmaceuticals market, the competition is also intense. These players are bringing several strategies and developments in the market to gain foothold in the market. Prominent players are expanding their reign by acquisitions, merging and collaborations. Some of the prominent players in the market are-

• Teva Pharmaceuticals Industries Limited
• JOHNSON & JOHNSON
• Shire Plc.
• Novartis AG
• Hoffmann-La Roche AG
• Pfizer Inc.
• Merck & Co.
• Sanofi S.A.

Scope of the Report

By Product

• Liposomes
• Polymeric micelles

By Application

• Drug delivery
• oncology
• neurology
• anti-inflammatory
• anti-infective,
• other applications.

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report 

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.